Reaction
Sarcoid-Like Reaction reporting signals
As of the last recalculation, Sarcoid-Like Reaction appears in 229 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-FKJP (PRR 112.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Fkjp | 46 | 112.7 | 112.8 |
| Adalimumab-Aaty | 46 | 110.3 | 110.4 |
| Adalimumab-Adaz | 46 | 98.9 | 99.0 |
| Pertuzumab | 23 | 85.4 | 85.4 |
| Dabrafenib | 13 | 59.4 | 59.4 |
| Polatuzumab Vedotin | 5 | 47.6 | 47.6 |
| Trametinib | 12 | 47.6 | 47.6 |
| Trastuzumab | 28 | 42.1 | 42.1 |
| Pembrolizumab | 39 | 40.4 | 40.4 |